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The effect of arginine-specific reagents on the activity of the partially purified and reconstituted tricarboxyl- 
ate carrier of the inner mitochondrial membrane has been studied. It has been found that l,Zcyclohexanedi- 
one, 2,3_butanedione, phenylglyoxal and phenylglyoxal derivatives inhibit the reconstituted citrate/citrate 
exchange activity. The inhibitory potency of the phenylglyoxal derivatives increases with increasing hydro- 
philic character of the molecule. Citrate protects the tricarboxylate carrier against inactivation caused by 
the arginine-specific reagents. Other tricarboxylates, which are not substrates of the carrier, have no protec- 
tive effect. The results indicate that at least one essential arginine residue is located at the substrate-binding 
site of the tricarboxylate carrier and that the vicinity of the essential arginine(s) has a hydrophilic character. 
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1. INTRODUCTION 
The inner mitochondrial membrane contains a 
specific carrier system for the transport of citrate 
known as the tricarboxylate carrier (review [l]). 
This system catalyzes an electroneutral strict 
counterexchange of citrate (isocitrate or 
phosphoenolpyruvate) and malate, which is impor- 
tant for metabolic processes uch as fatty acid syn- 
thesis, gluconeogenesis and transfer of reducing 
equivalents across the membrane [1,2]. Kinetic 
studies have shown that the activity of the tricar- 
boxylate carrier is high in liver compared to that in 
heart and brain [3-51 and that the carrier has a 
single binding site for all its substrates [3]. Further- 
more, the tricarboxylate carrier is inhibited 
specifically and competitively by the impermeable 
substrate analogue 1,2,3-benzenetricarboxylate 
131. 
In a previous paper we have partially purified 
+ To whom correspondence should be addressed 
the tricarboxylate carrier from rat liver mitochon- 
dria and reconstituted its activity in liposomeo 
[6,7]. As in the case of the phosphate carrier 
[g-lo], the citrate carrier also has an essential re- 
quirement for cardiolipin [6,11]. 
To obtain further information on the molecular 
mechanism of citrate transport in mitochondria, it 
is important to investigate the role of the essential 
functional groups of the carrier protein. Here, we 
report the effect of phenylglyoxal and other 
arginine-specific reagents on the activity of the 
partially purified and reconstituted tricarboxylate 
carrier. It is known that the cy-dicarbonyl reagents 
specifically bind to arginyl residues and therefore 
are potent inhibitors of several enzymes [121 and of 
the anion translocator in erythrocyte membranes 
[13-151. 
We have found that the reconstituted citrate 
transport activity is inhibited by phenylglyoxal, 
1,2-cyclohexanedione, 2,3-butanedione and more 
strongly by the phenylglyoxal chromophoric 
derivatives p-nitrophenylglyoxal, p-hydroxyphe- 
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nylglyoxal and 4-hydroxy-3-nitrophenylglyoxal. 
2. MATERIALS AND METHODS 
Hydroxyapatite (Bio-Gel HTP) and AGI x 8 
(100-200 mesh, acetate form) were purchased 
from Bio-Rad, [1,5-r4C]citric acid from the 
Radiochemical Centre (Amersham), cardiolipin 
from Avanti Polar Lipids, egg yolk phospholipids 
and 2,3-butanedione from Fluka, phenylglyoxal 
from Aldrich and 1,2-cyclohexanedione from K&K 
Laboratories. p-Nitrophenylglyoxal, p-hydroxy- 
phenylglyoxal and 4-hydroxy-3-nitrophenylglyoxal 
were synthesized by L.Z. All other reagents were 
obtained as reported [6]. 
Rat liver mitochondria were isolated by standard 
procedures. Solubilization of mitochondria, 
purification of the tricarboxylate carrier by 
hydroxyapatite chromatography and reconstitu- 
tion of the hydroxyapatite eluate in liposomes 
prepared in the presence of 20 mM citrate were 
carried out as in [6]. After removal of the external 
citrate by an AG 1 x 8 column (acetate form), the 
proteoliposomes were incubated at pH 7.4 with the 
arginine-specific reagents. After 40 min at 3O”C, 
citrate/citrate exchange was initiated by adding 
0.6 M [r4C]citrate and stopped 10 min later by 
10 mM 1,2,3-benzenetricarboxylate. Deviations 
from this procedure are indicated in the figure 
legends. In the control samples 1,2,3_benzenetri- 
carboxylate was added together with [14C]citrate. 
The citrate/citrate exchange activity was calculated 
by subtracting the control values from the ex- 
perimental samples [3,6]. Protein was determined 
by the Lowry method modified for the presence of 
Triton [16]. 
4-Hydroxy-3-nitrophenylglyoxal is the most effec- 
tive inhibitor. The half-maximal inhibition of 
citrate/citrate exchange activity in liposomes was 
found to be 0.7 mM for 4-hydroxy-3-nitrophenyl- 
glyoxal, 2.4 mM for p-hydroxyphenylglyoxal, 
3.2 mM for p-nitrophenylglyoxal and 4.1 mM for 
phenylglyoxal. In addition, two other reagents 
which are very specific for arginine residues in pro- 
teins, 1 ,Zcyclohexanedione and 2,3-butanedione 
(in the dark), were found to inactivate the re- 
constituted citrate transport activity. As compared 
with the phenylglyoxal derivatives, however, 
higher concentrations were necessary for inhibition 
(fig.lB). The concentrations required to achieve 
50% inhibition were 15 and 23 mM for 1,2-cyclo- 
hexanedione and 2,3-butanedione, respectively. 
Almost identical inhibition curves (not shown) 
were obtained when the tricarboxylate carrier was 
titrated with arginine reagents directly in the 
hydroxyapatite luate before its reconstitution into 
liposomes. 
The time course of the inhibition of the 
reconstituted citrate transport activity by different 
concentrations of phenylglyoxal is shown in fig.2. 
The inhibition is time-dependent and increases in 
relation to the concentration of the inhibitor. 
3.2. Effect of pH on the inhibition of the 
reconstituted citrate transport activity by 
phenylglyoxal 
3. RESULTS 
3.1. Inhibition of the citrate/citrate exchange 
activity in reconstituted liposomes by various 
arginine-specific reagents 
As shown in fig.3, the pH has a significant in- 
fluence on the inhibition of the reconstituted 
citrate/citrate exchange activity by phenylglyoxal. 
The inhibition increases with increasing pH from 
6.2 to 8.0 indicating that the pK of the reacting 
group(s) is rather high [12]. However, the ex- 
periments reported here were mainly carried out at 
pH 7.4 because the activity of the tricarboxylate 
carrier shows a maximum at about pH 7.0 [3,6]. 
The pH optimum of the modified carrier is the 
same as for the unmodified carrier (not shown). 
The effects of the a-dicarbonyl reagent 3.3. Protection of the reconstituted citrate/citrate 
phenylglyoxal and its chromophoric analogues p- exchange activity against inactivation caused 
nitrophenylglyoxal, p-hydroxyphenylglyoxal and by arginine-specific reagents 
4-hydroxy-3-nitrophenylglyoxal on reconstituted The protective effect of citrate with respect o in- 
citrate transport activity are shown in fig.lA. All activation of the tricarboxylate carrier by 5 mM 
these arginine-specific reagents inhibit the phenylglyoxal is shown in fig.4. The concentra- 
reconstituted exchange, although different concen- tions of citrate applied during the incubation of the 
trations are necessary for 50% inhibition. proteoliposomes with the inhibitor were 0.6 and 
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Fig. 1. Effect of various arginine-specific reagents on the reconstituted citrate/citrate exchange activity. The 
reconstituted liposomes were incubated with the indicated amounts of phenylglyoxal (x), p-nitrophenylglyoxal (A), p- 
hydroxyphenylglyoxal (0) and 4-hydroxy-3-nitrophenylglyoxal (0) in A and of 1 ,Zcyclohexanedione (x) and 
2,3-butanedione (0) in B. 
2.0 mM, i.e. about 2- and 7-times higher than the 
K,,, value [6]. The activity was measured in all cases 
in the presence of 2 mM external [14C]citrate. The 
results show that the protection is dependent on 
citrate concentration, reaching 64% protection in 
the presence of 2 mM citrate. When, on the other 
hand, 1,3,5_pentanetricarboxylate, which is 
chemically very similar to citrate, but which is no 
substrate of the carrier [3], is added to the pro- 
teoliposomes instead of citrate, no protection 
against inhibition by phenylglyoxal is achieved 
(fig.4). In agreement with this observation 
citrate/citrate exchange is not inhibited by adding 
1,3,5_pentanetricarboxylate alone. In other ex- 
periments (not shown) it was found that citrate 
also protects the reconstituted citrate/citrate ex- 
change activity against inactivation by 4-hydroxy- 
TIMECmtn) 
Fig.2. Time course of the inhibition of the reconstituted Inhibitor concentration was 1.5 mM (m), 3 mM (0) and 
citrate/citrate exchange by phenylglyoxal. The time of 9 mM (A). The activity of the untreated carrier was 
incubation with the inhibitor was varied as indicated. 1030pmol citrate- 10 min-l-g protein-‘. 
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Fig.3. pH dependence of the inhibition of the 
reconstituted citrate transport by phenylglyoxal. The 
proteoliposomes were incubated at the indicated pH 
values with and without 7 mM phenylglyoxal. 
3-nitrophenylglyoxal, which is the most potent in- 
hibitor among the a-dicarbonyl reagents tested (see 
fig.1). In contrast, other tricarboxylates such as 
1,3,5-pentanetricarboxylate, 1,3,5_benzenetricar- 
boxylate and trans-aconitate, which are neither 
substrates nor inhibitors of the tricarboxylate car- 
rier [3], do not exhibit any protection. 
4. DISCUSSION 
The reconstituted tricarboxylate carrier is in- 
hibited by arginine-specific reagents such as 
phenylglyoxal, phenylglyoxal derivatives and two 
other a-dicarboxyl compounds 1 ,Zcyclohexanedi- 
one and 2,3-butanedione. 
Among all the arginine-specific reagents tested, 
the phenylglyoxal derivative 4-hydroxy-3-nitro- 
phenylglyoxal is the most effective inhibitor. p- 
Hydroxyphenylglyoxal is less effective than 
4-hydroxy-3-nitrophenylglyoxal, but more than p- 
nitrophenylglyoxal and phenylglyoxal (fig.1). It is 
interesting that the inhibitory potency of the 
phenylglyoxal derivatives on the mitochondrial 
tricarboxylate carrier correlates well with the 
hydrophilicity of these compounds, as determined 
by Zaki [17]. This suggests that the vicinity of the 
essential arginine(s) has a hydrophilic character. In 
contrast, it should be noted that the same correla- 
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Fig.4. Protection of the reconstituted citrate transport 
activity against inhibition by phenylglyoxal. The 
proteoliposomes were incubated for the times indicated 
with 5 mM phenylglyoxal inthe absence (x) or presence 
of 0.6 mM (0) and 2 mM (0) citrate, and 0.6 mM (0) 
and 2 mM (w) 1,3,5-pentanetricarboxylate. In parallel 
experiments the proteoliposomes were incubated for the 
indicated times with no addition (A) or with 2 mM 
1,3$pentanetricarboxylate (A). The citrate/citrate 
exchange was initiated by adding carrier-free [ 14C]citrate 
(O), 2 mM [14C]citrate (x, q , n , A, A) or 1.4 mM 
[‘4C]citrate (0) and stopped 5 min later with 20 mM 
1,2,3-benzenetricarboxylate. Th  control activity was 
715 pm01 citrate.5 min-’ -g protein-‘. 
tion has not been found with the anion- 
transporting system of erythrocytes [17]. It is 
known that 2,3-butanedione is highly selective for 
modification of arginyl residues in proteins when 
used in the dark. This reagent is usually used in the 
presence of borate buffer which stabilizes the ad- 
duct between the guanidino group and the in- 
hibitor [12]. However, it was not possible to use 
borate buffer in the present experiments ince it 
caused a high degree of inactivation of the re- 
constituted citrate/citrate exchange activity. This 
may explain why rather high concentrations of 
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2,3-butanedione are required for inhibition of the 
tricarboxylate carrier. As shown in fig. 1, the 
degree of inhibition of the reconstituted citrate/ 
citrate exchange activity by 1 ,Zcyclohexanedione 
is higher than that caused by 2,3-butanedione. It 
should be noted that the arginine-specific reagents 
do not induce leakage of the proteoliposomes ince 
the loss of internal radioactivity after application 
of the maximal concentration of reagents was less 
than lo-15% (not shown). Although the in- 
hibitory effect of phenylglyoxal increases with in- 
creasing pH, all experiments were performed at pH 
7.4 to avoid inhibition of citrate transport by high 
pH. On the other hand, phenylglyoxal has been 
reported to have the highest selectivity for arginine 
residues at pH 7.4 [18]. 
Citrate, the substrate of the tricarboxylate car- 
rier, can protect the reconstituted transport activi- 
ty against the inactivation caused by 
arginine-specific reagents. In contrast, other tricar- 
boxylates which are not substrates of the carrier 
show no protective effect. 
These results indicate that the tricarboxylate car- 
rier possesses one (or more than one) essential 
arginine residue present at the substrate-binding 
site and located in a hydrophilic environment. 
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